Skip to content

Advertisement

  • Poster presentation
  • Open Access

Effect of interferon gamma on sepsis-related death in patients with immunoparalysis

  • 1,
  • 1,
  • 1,
  • 1 and
  • 1
Critical Care20048 (Suppl 1) :P207

https://doi.org/10.1186/cc2674

  • Published:

Keywords

  • Phorbol
  • Interferon Gamma
  • Myristate
  • Ionomycin
  • Myristate Acetate
Impaired host defense mechanisms following surgical stress such as burn, major surgery and polytrauma are considered important for the development of infectious complications and sepsis. We tested whether interferon (IFN) gamma can improve monocytic and lymphocytic functions and can reduce deaths related to sepsis. In order to restore their antimicrobial defense capacity, recombinant human IFN-gamma, 100 μg, was administered intravenously once daily to six immunoparalyzed patients. Informed consent was obtained from patients in all cases, and the study received local hospital ethical committee approval. Intracytoplasmic Th1 and Th2 cytokine production in isolated peripheral blood mononuclear cells was assessed by flow cytometry following in vitro activation by phorbol myristate acetate plus ionomycin. Monocytic human leukocyte antigen-DR (HLA-DR) expression was also measured. Immunoparalysis was defined as a decreased level of HLA-DR expression of monocytes <30% or a decreased level of Th1 <10%. IFN-gamma applied to immunoparalytic patients with low monocytic HLA-DR expression restored the deficient HLA-DR expression and in vitro Th1 cytokine production completely within 3 days. Recovery from immunoparalysis resulted in clearance of sepsis in four of six patients. IFN-gamma administration in septic patients accompanied with immunoparalysis is a new therapeutic strategy.

Table 1

Age (years)

HLA-DR (%) before IFN

HLA-DR (%) 3 days after IFN

Th1 (%) before IFN

Duration of IFN treatment (days)

Outcome

Diagnosis

45

27.9

43

4

12

Dead

Flame burn

72

7.5

19

3

12

Dead

Ileus

30

8

21

2.2

3

Dead

Pneumonia

37

25.1

33

9

12

Live

Peritonitis

56

29.7

74

9

7

Live

Peritonitis

75

27

56

8.9

5

Live

Pneumonia

Authors’ Affiliations

(1)
Kansai Medical University, Osaka, Japan

Copyright

© BioMed Central Ltd. 2004

Advertisement